Login / Signup

Molecular mechanism of extracutaneous tumours in patients with basal cell nevus syndrome.

Babette J A VerkouterenGuido Mjm RoemenJanneke Hm Schuurs-HoeijmakersMyrurgia Abdul HamidMichel van GeelErnst-Jan M SpeelKlara Mosterd
Published in: Journal of clinical pathology (2022)
Basal cell nevus syndrome (BCNS) is a rare genetic disorder accompanied by a broad variety of tumours, of which basal cell carcinomas and odontogenic keratocysts are the most common. BCNS is caused by a germline or postzygotic mutation in either PTCH1 or SUFU As BCNS is a rare disease, it is difficult to establish whether less frequently occurring tumours are actually part of the syndrome. In this study, the molecular mechanism behind four extracutaneous tumours in patients with BCNS was elucidated. A leiomyoma of the testis and meningioma were confirmed to be associated with BCNS in two patients by presence of a second mutation or loss of heterozygosity in PTCH1 In a meningioma of a patient with a mosaic postzygotic PTCH1 mutation an association could not be conclusively confirmed. SUFU was probably not involved in the development of a thyroid carcinoma in a patient with a germline SUFU mutation. Hence, we have proven that meningioma and leiomyoma of the testis are rare extracutaneous tumours that are part of BCNS.
Keyphrases
  • case report
  • single cell
  • cell therapy
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • peritoneal dialysis
  • genome wide
  • mesenchymal stem cells
  • optic nerve
  • copy number